The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in income, its exclusivity period created a deluge of generic competition , significantly impacting its market share . While specific firms may try to capitalize on male sexual dysfunction, the presen